0001140361-21-027415.txt : 20210806
0001140361-21-027415.hdr.sgml : 20210806
20210806200034
ACCESSION NUMBER: 0001140361-21-027415
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210804
FILED AS OF DATE: 20210806
DATE AS OF CHANGE: 20210806
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kennedy Brendan
CENTRAL INDEX KEY: 0001746070
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 211154316
MAIL ADDRESS:
STREET 1: 1920 EASTLAKE AVENUE E.
CITY: SEATTLE
STATE: WA
ZIP: 98105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 824310622
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 655 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
BUSINESS PHONE: 519.322.8800
MAIL ADDRESS:
STREET 1: 655 MADISON AVENUE
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10065
4
1
form4.xml
FORM 4
X0306
4
2021-08-04
0001731348
Tilray, Inc.
TLRY
0001746070
Kennedy Brendan
C/O TILRAY, INC.
655 MADISON AVENUE, 19TH FLOOR
NEW YORK
NY
10065
true
Class 2 Common Stock
2021-08-04
4
S
0
300000
14.0809
D
8274196
D
Class 2 Common Stock
2021-08-05
4
S
0
300000
14.4619
D
7974196
D
Class 2 Common Stock
234940
I
By: Skyline & Mayfair LLC
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.54, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.89 to $14.74, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
The reporting person is the sole member of Skyline & Mayfair LLC and has sole voting and investment power with respect to the shares held by Skyline & Mayfair LLC.
/s/ Carl A. Merton, as attorney-in-fact for Brendan Kennedy
2021-08-06